FDA Approved: PITAVASTATIN — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for pitavastatin calcium under ANDA205955. The approval pertains to the generic pitavastatin product submitted by Upsher…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Hyperlipidemia

Drugs mentioned

• PITAVASTATIN CALCIUM (PITAVASTATIN CALCIUM)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN CALCIUM)